KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 42 filers reported holding KALEIDO BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,026,000 | -31.0% | 1,833,832 | 0.0% | 0.62% | +10.4% |
| Q4 2021 | $4,383,000 | -56.2% | 1,833,832 | 0.0% | 0.56% | -40.5% |
| Q3 2021 | $10,013,000 | -26.6% | 1,833,832 | 0.0% | 0.94% | -27.8% |
| Q2 2021 | $13,644,000 | -8.1% | 1,833,832 | 0.0% | 1.30% | -34.5% |
| Q1 2021 | $14,854,000 | -11.0% | 1,833,832 | 0.0% | 1.99% | -69.5% |
| Q4 2020 | $16,688,000 | -28.8% | 1,833,832 | -4.5% | 6.52% | -24.8% |
| Q3 2020 | $23,435,000 | +72.0% | 1,920,027 | +4.7% | 8.67% | +47.7% |
| Q2 2020 | $13,625,000 | +89.8% | 1,833,832 | +57.1% | 5.87% | +69.5% |
| Q1 2020 | $7,178,000 | +22.5% | 1,167,166 | 0.0% | 3.46% | +43.6% |
| Q4 2019 | $5,859,000 | -33.3% | 1,167,166 | 0.0% | 2.41% | -34.0% |
| Q3 2019 | $8,789,000 | -67.5% | 1,167,166 | -50.0% | 3.66% | -27.8% |
| Q2 2019 | $27,078,000 | +60.0% | 2,334,332 | +100.0% | 5.06% | -15.4% |
| Q1 2019 | $16,924,000 | – | 1,167,166 | – | 5.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 17,360,710 | $106,768,000 | 5.00% |
| HARBOURVEST PARTNERS LLC | 1,167,166 | $7,178,000 | 3.46% |
| Palo Alto Investors LP | 787,999 | $4,846,000 | 0.41% |
| Artal Group S.A. | 500,500 | $3,078,000 | 0.13% |
| BAINCO INTERNATIONAL INVESTORS | 22,037 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $656,000 | 0.02% |
| Baillie Gifford | 440,000 | $2,706,000 | 0.00% |
| FMR LLC | 2,276,007 | $13,997,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 250,372 | $1,540,000 | 0.00% |